VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 04/30/2023 | 10/31/2022 | 07/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 4.98M | 5.18M | 5.18M | 6.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 4.98M | 5.18M | 5.18M | 6.57M |
| Cost of Revenue | -- | 2.95M | 3.13M | 3.13M | 4.18M |
| Gross Profit | -- | 2.03M | 2.05M | 2.05M | 2.39M |
| SG&A Expenses | -- | 848.50K | 818.90K | 823.10K | 740.90K |
| Depreciation & Amortization | -- | 7.60K | 11.40K | 7.60K | 4.60K |
| Other Operating Expenses | -- | 400.00 | 400.00 | 400.00 | 700.00 |
| Total Operating Expenses | -- | 3.80M | 3.96M | 3.96M | 4.92M |
| Operating Income | -- | 1.17M | 1.22M | 1.22M | 1.65M |
| Income Before Tax | -- | 1.18M | 1.23M | 1.23M | 1.65M |
| Income Tax Expenses | -- | 246.00K | 291.60K | 291.60K | 321.90K |
| Earnings from Continuing Operations | -- | 0.94 | 0.94 | 0.94 | 1.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 936.00K | 936.50K | 936.50K | 1.33M |
| EBIT | -- | 1.17M | 1.22M | 1.22M | 1.65M |
| EBITDA | -- | 1.19M | 1.24M | 1.24M | 1.66M |
| EPS Basic | -- | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Basic EPS | -- | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | -- | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Diluted EPS | -- | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | -- | 826.09M | 825.02M | 825.02M | 823.96M |
| Average Diluted Shares Outstanding | -- | 826.09M | 825.02M | 825.02M | 823.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |